Skip to main content
Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
2.865
-0.005 (-0.17%)
At close: Apr 29, 2025, 4:00 PM
2.870
+0.005 (0.17%)
Pre-market: Apr 30, 2025, 8:22 AM EDT

Theratechnologies Revenue

Theratechnologies had revenue of $19.05M in the quarter ending February 28, 2025, with 17.23% growth. This brings the company's revenue in the last twelve months to $88.67M, up 13.52% year-over-year. In the fiscal year ending November 30, 2024, Theratechnologies had annual revenue of $85.87M with 5.02% growth.

Revenue (ttm)
$88.67M
Revenue Growth
+13.52%
P/S Ratio
1.48
Revenue / Employee
$860,835
Employees
103
Market Cap
131.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202485.87M4.10M5.02%
Nov 30, 202381.76M1.71M2.13%
Nov 30, 202280.06M10.23M14.66%
Nov 30, 202169.82M3.77M5.71%
Nov 30, 202066.05M2.84M4.49%
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

THTX News

More News